SCHEMBL20569353

SCHEMBL20569353

CC(C)(C)[Si](C)(C)OCc1cc(I)on1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4882325 0.81 CNR2 (0.39)
SCHEMBL24096652 0.79
SCHEMBL22224153 0.77
SCHEMBL25095295 0.76 SMN1; SMN2 (0.31)
SCHEMBL5099353 0.71 PPARA (0.38)
SCHEMBL4853136 0.71 PPARA (0.38)
SCHEMBL2254668 0.71 MEN1 (0.31)
SCHEMBL2251477 0.71 NOTUM (0.36)
SCHEMBL3759539 0.71 MEN1 (0.31)
SCHEMBL13008101 0.70 IDO1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220002279-A1 NOVEL IMIDAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2022-01-06 US disclosed
US-20220002279-A1 NOVEL IMIDAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2022-01-06 US disclosed
EP-3884940-A1 NOVEL IMIDAZOLE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2021-09-29 EP disclosed
EP-3884940-A1 NOVEL IMIDAZOLE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2021-09-29 EP disclosed
CN-112996505-A Novel imidazole derivatives 大正制药株式会社 2021-06-18 CN disclosed
WO-2018216822-A1 NOVEL IMIDAZOLE DERIVATIVES TAISHO PHARMACEUTICAL CO., LTD. (JP) 2018-11-29 WO disclosed